Navigation Links
Luminex Corporation To Present At Upcoming Investment Conferences In September
Date:9/12/2012

AUSTIN, Texas, Sept. 12, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at two upcoming investment conferences, the UBS Global Life Sciences Conference and the Credit Suisse 2012 Small & Mid Cap Conference, both scheduled to take place in New York City.  

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Patrick J. Balthrop, president and chief executive officer, will present at the UBS Global Life Sciences Conference on September 19, 2012 at 1 p.m. Eastern time, and at the Credit Suisse 2012 Small & Mid Cap Conference on September 21, 2012 at 1:10 p.m. Eastern time.

The presentations will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com.  Simply log on to the web at the address above, go to the Company section and access the Investor Relations link.  Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.

Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. We are transforming global healthcare and life-science research through the development, manufacturing, and marketing of proprietary instruments and assays utilizing our xMAP® open-architecture, multi-analyte platform and our MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies that deliver cost-effective and rapid results to clinicians and researchers. Our technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies.  We are meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.  For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology please visit our website at http://www.luminexcorp.com.

 Contacts:

Harriss T. CurrieVice President, Finance and Chief Financial Officer512-219-8020Matthew ScaloSr. Director of Investor Relations512-219-8020mscalo@luminexcorp.com


'/>"/>
SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Luminex Corporation Hosts 10th Annual Planet xMAP Symposium in Monaco
2. Luminex Corporation Recognized as Best Technology Company in Austin
3. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
4. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
5. Luminex Corporation Reports Second Quarter 2012 Results
6. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
7. Luminex Corporation Announces Agreement to Acquire GenturaDx
8. Luminex Corporation Reports First Quarter 2012 Results
9. Genelex Corporation Rolls Out Lifesaving DNA Healthcare System
10. Tranzbyte Corporation Acquires the Exclusive Right to Market Low-Cost, Innovative MRI machines in North and South America
11. American Pacific Corporation Completes Redemption Of $40 Million Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent Medical, ... Aufnahme von Patienten für eine Studie zur Sicherheit ... („WEB") speziell für die Behandlung von rupturierten intrakraniellen ... MD, Leiter der Neuroradiologie an der Universitätsklinik Bicètre ... Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten aufgenommen. ...
(Date:2/12/2016)... SAN DIEGO and SEOUL, ... -- Silicon Biosys­tems Menarini and Macrogen, Inc. today ... clinical assays and innovative procedures for precision medicine ... to combine Silicon Biosystems, DEPArray™ digital-sorting technology with ... development of tests certified under the Clinical Laboratory ...
(Date:2/12/2016)... 12 februari 2016 AAIPharma Services ... leverancier van productie en ontwikkeling op maat ... vandaag een uitbreiding aan van steriele vul- ... in Charleston, SC . ... meerdere recente investeringen. http://photos.prnewswire.com/prnh/20150806/256637LOGO ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on ...
(Date:2/12/2016)... Los Angeles, CA (PRWEB) , ... February 12, 2016 , ... ... be. With a hectic schedule, a demanding job, and no time to decompress, Rabinowitz ... there, she dedicated herself to meditation for its impact on her life, implementing a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Itopia, a leader in ... of Clarity Intelligence Platform (CIP) into Cielo®, a discovery, migration and cloud orchestration ... to their small and medium business (SMB) clients. , In recent ...
(Date:2/12/2016)... ... ... The Jones Agency, a family owned insurance company with offices serving Arlington, ... drive with the Tarrant Area Food Bank in the hopes of alleviating hunger for ... the Tarrant County Food Bank offers hope and security to the one in six ...
(Date:2/12/2016)... ... , ... Donor Network West, the organ procurement organization that heals lives through ... Ramon Regional Medical Center. Under the collaboration, the first of its kind, specific organ ... more certain time frame for donor families for the recovery of organs. , ...
Breaking Medicine News(10 mins):